777 game
2025-01-12   

777 game
777 game Brice Williams scored 21 of his game-high 32 points in the second half Monday night as Nebraska advanced to the final of the Diamond Head Classic with a 69-55 win over Hawaii in Honolulu. Juwan Gary added 21 for the Cornhuskers (9-2), who will play Oregon State on Wednesday in the championship game. The Beavers scored an 80-74 overtime win over Oakland in the first semifinal. Marcus Greene scored 11 points, while Kody Williams and reserve Akira Jacobs each scored 10 for the Rainbow Warriors (7-4). But forward Gytis Nemeiksa, who averages 15 points per game and tallied 24 in a win Sunday night over Charlotte, missed all five shots from the field and mustered just one point in 24 minutes. Brice Williams ripped off seven of Nebraska's first nine points in the second half during a 9-2 run that gave the Cornhuskers the lead for good at 38-33 with 17:17 left. Gary added the team's next nine points and Williams took over after that with a three-point play, a short jumper and a layup that made it 54-43 with 7:51 remaining. The Cornhuskers canned 59.3 percent of their shots in the second half. The first half was played in two distinct segments. Hawaii controlled the first 12 1/2 minutes, playing solid defense and carving out points with good offensive execution. A layup by Jacobs gave the Rainbow Warriors a 22-14 lead at the 8:41 mark. Nebraska then ripped off 15 points in a 5:59 span, starting with a short hook from Brandon Meah and culminating with Williams' long 3-pointer from the wing with 1:04 left that gave it a 29-22 advantage. The Rainbow Warriors missed 11 straight shots and went 8:01 without a point. But they headed for halftime with momentum after a layup by Harry Rouhliadeff and Greene's buzzer-beating 3-pointer as the horn sounded, enabling Hawaii to slice the deficit to 29-27. Neither team shot better than 35.7 percent in the opening 20 minutes, but the Cornhuskers were more efficient on 3-pointers, going 5 of 12 while Hawaii was just 4 of 16. --Field Level Media

Geode Capital Management LLC lessened its position in Under Armour, Inc. ( NYSE:UAA – Free Report ) by 8.0% during the third quarter, Holdings Channel reports. The institutional investor owned 2,881,081 shares of the company’s stock after selling 249,650 shares during the quarter. Geode Capital Management LLC’s holdings in Under Armour were worth $25,679,000 as of its most recent SEC filing. Other hedge funds and other institutional investors also recently made changes to their positions in the company. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Under Armour by 49.1% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 171,435 shares of the company’s stock worth $1,143,000 after acquiring an additional 56,440 shares in the last quarter. Panagora Asset Management Inc. raised its holdings in Under Armour by 104.0% in the 2nd quarter. Panagora Asset Management Inc. now owns 27,073 shares of the company’s stock valued at $181,000 after acquiring an additional 13,801 shares during the period. iA Global Asset Management Inc. grew its position in shares of Under Armour by 30.4% in the second quarter. iA Global Asset Management Inc. now owns 70,323 shares of the company’s stock valued at $469,000 after purchasing an additional 16,377 shares during the last quarter. Commonwealth Equity Services LLC increased its stake in shares of Under Armour by 14.7% during the second quarter. Commonwealth Equity Services LLC now owns 103,150 shares of the company’s stock worth $688,000 after purchasing an additional 13,209 shares during the period. Finally, Privium Fund Management B.V. lifted its holdings in Under Armour by 1.5% during the 2nd quarter. Privium Fund Management B.V. now owns 226,200 shares of the company’s stock worth $1,457,000 after purchasing an additional 3,300 shares during the last quarter. 34.58% of the stock is currently owned by institutional investors and hedge funds. Under Armour Stock Performance NYSE:UAA opened at $8.38 on Friday. The company has a quick ratio of 1.24, a current ratio of 2.18 and a debt-to-equity ratio of 0.30. The firm has a market capitalization of $3.62 billion, a PE ratio of -279.24 and a beta of 1.69. Under Armour, Inc. has a twelve month low of $6.17 and a twelve month high of $11.89. The stock’s 50-day simple moving average is $9.28 and its 200 day simple moving average is $8.14. Wall Street Analyst Weigh In Read Our Latest Analysis on Under Armour Insider Transactions at Under Armour In other news, insider Mehri Shadman sold 9,639 shares of the stock in a transaction on Monday, November 18th. The stock was sold at an average price of $8.81, for a total value of $84,919.59. Following the completion of the transaction, the insider now directly owns 172,899 shares in the company, valued at approximately $1,523,240.19. This represents a 5.28 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink . Also, CFO David Bergman sold 30,000 shares of the business’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $9.09, for a total value of $272,700.00. Following the sale, the chief financial officer now owns 494,210 shares in the company, valued at $4,492,368.90. This represents a 5.72 % decrease in their position. The disclosure for this sale can be found here . Over the last 90 days, insiders sold 56,879 shares of company stock valued at $508,642. 15.60% of the stock is currently owned by insiders. Under Armour Company Profile ( Free Report ) Under Armour, Inc, together with its subsidiaries, engages developing, marketing, and distributing performance apparel, footwear, and accessories for men, women, and youth. The company provides its apparel in compression, fitted, and loose fit types. It also offers footwear products for running, training, basketball, cleated sports, recovery, and outdoor applications. Featured Stories Want to see what other hedge funds are holding UAA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Under Armour, Inc. ( NYSE:UAA – Free Report ). Receive News & Ratings for Under Armour Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Under Armour and related companies with MarketBeat.com's FREE daily email newsletter .Attendees worked hands-on with a FlexArm tapping arm at Flex Machine Tools’ open house Thursday in Wapakoneta. Cade Higgins | The Lima News WAPAKONETA — The parking lot was full at Flex Machine Tools in Wapakoneta as attendees got a first-hand experience of the banging, drilling and whirring of machinery and technology. Located at 705 Commerce Drive in Wapakoneta, guests learned how FLEX technology boosts productivity and transforms operations. On demonstration was the FlexJet FLX waterjet; the FlexCNC C-series long-bed machining center; the new Flexible Tapping Center; a variety of pneumatic, electric and hydraulic tapping; and FlexERGO Arms designed for safe and ergonomic operations. Another event was planned Friday to be structured around scheduled demonstrations with a much more targeted group of around t10 people. Flex Machine Tools President Don Kemper began his tenure at Flex as vice president of operations in 2023 and took over as president shortly after. Visiting Flex as a customer to buy a machine tool for a former employer opened up Kemper’s eyes. When the opportunity came for him to join, he did just that. “I was impressed with the culture and the team here,” he said. “Everybody works together.” The same can be said for the open house event. Employees worked with attendees, showing them the ropes of various machine tools and guiding them along for tours. When a customer is interested in working with Flex, they must first identify a need for a piece of equipment. A time study and demonstration are conducted by the applications team to better assist the customer in understanding exactly how the machine operates. As the customer visits the facility for the part demonstrations, they see what drew Kemper in and what he continues to preach — culture. “When a customer visits the facility and interacts with our team and sees the culture and our equipment, the close rate on those opportunities is probably three times what is if they don’t visit our facility,” he said. Flex Machine Tools was founded in 1971 by Richard Kennedy as a government contractor. The FlexArm was developed by Kennedy in 1984. Flex works with automotive industries, job shops, machine shops, fab shops and aerospace industries. Reach Cade Higgins at 567-242-0351

SAN DIEGO, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced that Carl Hull will retire from his position as Executive Chairman of the Board and that the Board of Directors has unanimously elected R. Andrew Eckert to succeed him as Chairman of the Board, effective December 5, 2024. Carl Hull founded Maravai in 2014 and served as Chief Executive Officer, assuming the role of Executive Chairman in October 2022. “Leading Maravai has been the single most rewarding experience in my career. I am extremely proud of what we have accomplished together over the past 10 years,” stated Carl Hull. “I extend my sincere thanks to Trey Martin, our CEO, the rest of our leadership team and to the dedicated employees across the world who enthusiastically serve our customers and their communities every day. I am excited about the company’s future prospects and am confident that Maravai has the team, the talent, and the technology to deliver on its long-term objectives.” "On behalf of the entire Board, I thank Carl for his incredible commitment to Maravai since he founded the Company in 2014.” said Constantine (“Dean”) Mihas, Board member and Co-CEO of GTCR. “I congratulate him for his distinguished career and deeply appreciate his vision and unwavering service to building Maravai and positioning the company for long-term success. He has been a model of corporate leadership and integrity in our industry and beyond, and we wish him well in his well-deserved retirement." Mihas continued, “We also want to welcome Andy as our new Chair and Board member. Andy is a healthcare industry veteran with extensive experience as an executive officer of several healthcare companies. He brings deep knowledge of operations, strategic planning, product development and marketing to our Board and has valuable corporate governance insight gained from having served as Chief Executive Officer and Director of publicly held companies. We look forward to leveraging his impressive executive experience to help guide Maravai to achieve significant scale.” “I'm honored to join the Board of Directors at Maravai, a company dedicated to innovation to help our customers improve human health,” said Eckert. “I look forward to contributing to the success and transformative impact of this remarkable organization while concurrently driving long-term shareholder value." About R. Andrew Eckert Mr. Eckert is a Senior Adviser to Permira, a global private equity leader. Prior to Permira, he served as CEO of Zelis, a healthcare payments and cost containment business. Before Zelis, he served as CEO of wound care leader Kinetic Concepts, Inc. (KCI) from 2017 until its sale to 3M in 2019. Prior to joining KCI, he served as Chief Executive Officer of Valence Health, an emerging leader in value-based healthcare, until its sale in 2016. Andy previously served as Chief Executive Officer of TriZetto, a leader in payer information technology (acquired by Cognizant), and as Chairman and Chief Executive Officer of CRC Health Group, a leading behavioral health treatment provider (acquired by Acadia). Earlier in his career, he was Chief Executive Officer of Eclipsys Corporation from 2005 to 2009, and Chief Executive Officer of SumTotal Systems from 2002 to 2005. Andy began his career at ADAC Laboratories, including four years as Chairman and Chief Executive Officer until its sale to Philips Medical Systems in 2000. Andy has served on several corporate boards and is currently the Chairman of Kipu Health, Lead Director at Fortrea (NASDAQ: FTRE), and a Director at Becton, Dickinson and Company (NYSE: BDX). He was Chairman of Varian Medical Systems for seven years until its acquisition by Siemens Healthineers in 2021. He has a Bachelor of Science in Industrial Engineering and a Master of Business Administration, both from Stanford University. About Maravai Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world's leading biopharmaceutical, vaccine, diagnostics and cell and gene therapies companies. Forward-looking Statements This press release may contain "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Investors are cautioned that statements in this press release which are not strictly historical statements constitute forward-looking statements, including, without limitation, statements related to the expectation that Mr. Eckert will help Maravai achieve scale and drive long-term shareholder value, constitute forward-looking statements identified by words like “plan,” “will,” “expect,” “may,” “anticipate,” or “could” and similar expressions. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including, without limitation, the risks and uncertainties described in greater detail in the “Risk Factors” section of our most recent Annual Report on Form 10-K and other filings with the U.S. Securities and Exchange Commission. Actual results may differ materially from those contemplated by these forward-looking statements, and therefore you should not rely upon them. These forward-looking statements reflect our current views and we do not undertake to update any of these forward-looking statements to reflect a change in its views or events or circumstances that occur after the date hereof except as required by law.AP Business SummaryBrief at 2:42 p.m. EST

DEAR ABBY: I have been happily single for most of my life, and I treasure the friendship and company of my other women friends. My question concerns a situation that happens frequently when one of them starts dating or marries. They seem to feel I should enjoy the company of BOTH of them together from then on. My response has been to refuse any invitations, but it feels rude and impolite. I would appreciate your advice, and thank you! -- SINGLE LADY IN THE MIDWEST DEAR SINGLE LADY: Running away isn’t the answer. Instead of cutting off these women without explanation when they become involved in a romantic relationship, it would make more sense to point out to them that women (and men) communicate differently when members of the opposite sex are present. It’s the truth. Couples don’t have to be joined at the hip 100% of the time, and, in fact, it’s healthier for their relationship when they sometimes socialize as individuals. *** Dear Abby is written by Abigail Van Buren, also known as Jeanne Phillips, and was founded by her mother, Pauline Phillips. Contact Dear Abby at www.DearAbby.com or P.O. Box 69440, Los Angeles, CA 90069. Latest Advice Columns Dear Abby: I wish my father’s ex didn’t send a shoebox full of mementos from their relationship to me Dear Annie: Happy Holidays to All December 24 birthday horoscope and your daily astrology Miss Manners: My sister-in-law was angry that my nephew saw ‘embarrassing things’ in my medicine cabinet Asking Eric: Since my dad and brother passed away, my mother has been increasingly mean, angry and rude89bio to Participate in the 7th Annual Evercore HealthCONx Conference

Related hot word search:

Previous: uno game
Next: